Is tissue plasminogen activator a threat to neurons?

Nat Med. 2001 Jan;7(1):17-8. doi: 10.1038/83289.

Abstract

The clot-busting drug tissue plasminogen activator (tPA) is currently the only FDA-approved therapy for acute stroke. However, increasing evidence suggests that tPA can also contribute to excitotoxic neuronal damage in animal models of stroke.

Publication types

  • Comment

MeSH terms

  • Animals
  • Disease Models, Animal
  • Neurons / drug effects*
  • Neurons / pathology
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Stroke / drug therapy*
  • Stroke / pathology
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Receptors, N-Methyl-D-Aspartate
  • Tissue Plasminogen Activator